DYN FY 2011 Earnings — Dyne Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DYNDyne Therapeutics, Inc.

$3B

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.6B-31.8% YoY

Gross Profit

$622M39.2% margin

Operating Income

-$236M-14.9% margin

Net Income

-$1.6B-103.8% margin

EPS (Diluted)

$-13.48

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$262M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$4.1B

Total Liabilities

$3.0B

Stockholders' Equity

$1.1B

Cash & Equivalents

$396M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.6B	$2.3B	-31.8%
Gross Profit	$622M	$1.1B	-45.5%
Operating Income	-$236M	-$11M	-2045.5%
Net Income	-$1.6B	-$234M	-603.0%